Difference between revisions of "WSI21-141"

From MGH Learn Pathology
(Edited automatically from page learn:wsidashboard.)
 
(102 intermediate revisions by 7 users not shown)
Line 1: Line 1:
−
{{dziOrderStudySet
+
{{ServiceRequest
−
|order_date=July 06, 2021 01:07:38 PM
+
|intent=order
−
|user=Em99
+
|category=409073007
−
|class_name=Study Set
+
|priority=routine
−
|status=Created
+
|code=study
−
|collection_name=Cytopathology
+
|orderDetail=order
−
|class_type=Cytology
+
|authoredOn=July 06, 2021 01:07:38 PM
−
|collection_topic=Bone and Soft Tissue  
+
|requester=Em99
−
|requested_by=MBP
+
|locationCode=learn
−
|restrict_access=Public
+
|access=public
 +
|subject=MGH
 +
|performer=MGH
 +
|supportingInfo=Cytology
 +
|requisition=Cytology
 +
|reasonCode=Bone and Soft Tissue
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Si787
 +
|authoredOn=March 10, 2022 10:37:59 AM
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Apr 13, 2022 13:35:10
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Apr 13, 2022 13:40:23
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Apr 26, 2022 12:20:44
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Apr 28, 2022 17:50:42
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=May 02, 2022 19:49:17
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 20, 2022 16:26:53
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 20, 2022 16:29:36
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 20, 2022 18:24:58
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 22, 2022 14:37:21
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 22, 2022 14:37:32
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jul 22, 2022 19:02:36
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 01, 2022 14:54:52
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 03, 2022 15:02:57
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 05, 2022 17:16:22
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 10, 2022 14:27:48
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Cfh13
 +
|authoredOn=Aug 12, 2022 17:44:43
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Cfh13
 +
|authoredOn=Aug 12, 2022 17:46:51
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 16, 2022 14:10:47
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Aug 17, 2022 16:08:20
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Aug 17, 2022 16:11:15
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 19, 2022 15:16:46
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Aug 23, 2022 18:18:55
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Sep 02, 2022 15:17:40
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Cfh13
 +
|authoredOn=Sep 21, 2022 14:02:00
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Sep 29, 2022 17:58:18
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Sep 29, 2022 17:59:40
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Sep 30, 2022 14:53:15
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Oct 03, 2022 16:29:19
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Oct 03, 2022 16:29:41
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Oct 04, 2022 13:36:18
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Oct 04, 2022 14:35:06
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Oct 07, 2022 15:21:39
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Mlz8
 +
|authoredOn=Oct 28, 2022 20:13:23
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Mlz8
 +
|authoredOn=Oct 28, 2022 20:15:41
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Oct 31, 2022 19:26:46
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Ndk6
 +
|authoredOn=Nov 01, 2022 11:42:16
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Nov 04, 2022 13:38:37
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Nov 04, 2022 13:39:26
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Nov 04, 2022 13:39:54
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Nov 04, 2022 13:40:37
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Nov 30, 2022 18:04:46
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 14, 2023 17:35:00
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Feb 14, 2023 21:00:25
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 16, 2023 20:56:27
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 16, 2023 21:01:09
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 27, 2023 18:52:57
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 27, 2023 18:55:18
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 28, 2023 18:38:34
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Feb 28, 2023 18:40:01
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Mar 06, 2023 17:35:37
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Mar 09, 2023 18:40:33
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Mar 09, 2023 18:59:49
 
}}
 
}}
 
{{status
 
{{status
−
|requester=Em99
+
|status=active
−
|authoredOn=July 06, 2021 01:07:38 PM
+
|identifier=WSI21-141
−
|status=Created
+
|requester=Iac0
 +
|authoredOn=Apr 06, 2023 16:35:45
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Apr 06, 2023 16:39:38
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Ndk6
 +
|authoredOn=Apr 13, 2023 20:12:55
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Apr 24, 2023 18:19:34
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=May 01, 2023 18:38:33
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=May 01, 2023 19:02:37
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=May 01, 2023 19:26:08
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=May 24, 2023 13:54:09
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=May 24, 2023 14:03:37
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 01, 2023 13:01:13
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 01, 2023 14:56:10
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 01, 2023 17:39:38
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Ndk6
 +
|authoredOn=Jun 02, 2023 18:52:46
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 05, 2023 12:39:12
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 05, 2023 14:57:11
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 16:02:27
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 16:21:41
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 16:22:21
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 18:22:59
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 19:50:07
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jun 05, 2023 20:40:56
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 07, 2023 20:03:42
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 14, 2023 13:56:58
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jun 14, 2023 14:32:08
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jul 05, 2023 18:00:25
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-141
 +
|requester=Iac0
 +
|authoredOn=Jul 05, 2023 18:02:15
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 05, 2023 18:48:40
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 07, 2023 18:56:55
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-141
 +
|requester=Aja51
 +
|authoredOn=Jul 11, 2023 13:43:04
 
}}
 
}}

Latest revision as of 08:43, July 11, 2023


Request type Study
Subspecialty Cytology
Set Cytology
Topic Bone and Soft Tissue
Presenter MGH


Toggle columns: Diagnosis

Case Clinical history Requester Diagnosis
Case Clinical history Requester Diagnosis

Case 1


56-year-old male • neck mass. Iac0 Schwannoma

Case 2


68yo female with right foot pain/swelling around 2nd metatarsal x 2 months Mlz8 Gout tophus (collections of monosodium urate crystals and foreign body giant cells)

Case 3


70yo male with sacral mass Mlz8 Chordoma

Case 4


19 year-old-male. Pubic bone mass. Renal mass. Family history of cutaneous leiomyomas. Iac0 Metastatic papillary renal cell carcinoma • type 2. Likely hereditary leiomyomatosis and renal cell cancer syndrome.

Case 5


51F. Left masticator space. Iac0 Tenosynovial giant cell tumor.

Case 6


31 F. Hx of rhabdomyosarcoma. Mediastinal lymphadenopathy. Iac0 Metastatic rhabdomyosarcoma.

Case 7


78 y/old M with prior excised tumor in the head/ear Aja51 Melanoma with spindle cell morphology.

Case 8


74-year-old female with an ill-defined 6.7cm mass in the gastrosplenic ligament Sj82 Gastrointestinal stromal tumor (GIST)

Case 9


77 year old woman with a scalp nodule and a history of a sacral mass. Cfh13 Metastatic chondrosarcoma • conventional type.

Case 10


50F. History of leiomyosarcoma. Iac0 Metastatic leiomyosarcoma.

Case 11


52 yo male with a 2 week history of jaw mass with fevers • night sweats • and possible weight loss. 0.4 cm firm fixed mass. Ndk6 Diffuse large B-cell lymphoma

Case 12


86 yo female with a history of squamous cell carcinoma of right calf. Now presents with a large mass in the inner upper thigh/groin • which has a necrotic center. Ndk6 Squamous cell carcinoma

Case 13


27F. Hx of Ewing sarcoma Iac0 Metastatic Ewing sarcoma.

Case 14


31M with mediastinal mass Mlz8 Ganglioneuroma

Case 15


41 YO female with h/o undifferentiated carcinoma and new pelvic soft tissue mass Ndk6 Undifferentiated pleomorphic malignant neoplasm

Case 16


43M. Multiple lung nodules consistent with metastasis. No known primary. Iac0 Metastatic extraskeletal myxoid chondrosarcoma • with EWSR1::NR4A3.

Case 17


50F. Left pelvis. Parathyroid adenoma Iac0 Giant cell rich lesion. In correlation with clinical history • consistent with Brown tumor.

Case 18


46F. Left elbow mass. Iac0 Tenosynovial giant cell tumor (giant cell tumor of tendon sheath)

Case 19


77M. Lung mass. History of solitary fibrous tumor. Iac0 Metastatic solitary fibrous tumor.

Case 20


3M. Paraspinal mass. Iac0 Neuroblastoma

Case 21


49F. Right cheek mass. Iac0 Foreign body giant cell reaction to mucoid material • most consistent with dermal fillers.

Case 22


63F. Left hilar lung mass. Iac0 Cytology dx: Epithelioid neoplasm with myxoid matrix. EWSR1 FISH and fusion assay on cell block were negative for reportable fusions. Resection dx: SMARCB1-deficient neoplasm most consistent with malignant myoepithelioma.

Case 23


84 YO male with peri-stomal mass Ndk6 Chondrosarcoma

Case 24


43 YO male with enlarged lymph node and neck mass Ndk6 Metastatic chordoma • conventional type

Case 25


43M. History of chordoma. Iac0 Metastatic chordoma.

Case 26


74F. Pleural biopsy. Iac0 Solitary fibrous tumor.

Case 27


50M. Chest wall mass. Iac0 Low-grade leiomyosarcoma.

Case 28


36 year old male. Cheek. Iac0 Granular cell tumor.

Case 29


53 yo F with incidental 8.8 cm fluid-attenuating lesion arising from the aponeurosis of the external abdominal oblique muscle. Dark brown cyst contents on aspiration. Remainder of history unremarkable. Dl292 Clear cell carcinoma • likely arising in background endometriosis

Case 30


72M. Lung squamous cell carcinoma. Now with right temporalis muscle mass. On imaging • the tumor involving the right pterional calvarium and pachymeninges. Iac0 Meningioma.

Case 31


53M. History of atypical ossifying fibromxyoid tumor of chest wall. Iac0 Metastatic malignant ossifying fibromyxoid tumor.

Case 32


71M. Chest wall mass. Iac0 High-grade sarcoma • consistent with dedifferentiated liposarcoma (MDM2 amplification confirmed on surgical pathology).

Case 33


25 yo M with h/o metastatic alveolar rhabdomyosarcoma (PAX3::FOXO1 fusion) to prostate and retroperitoneal lymph nodes. Now presents with a 2.1 cm subcutaneous mass on left chest. Tz046 Metastatic alveolar rhabdomyosarcoma.

Case 34


52M. 4.5 cm R TMJ mass. Iac0 Tenosynovial giant cell tumor.

Case 35


40M. Hx of myxoinflammatory fibroblastic sarcoma of left arm. Now with mass proximal to prior resection. Iac0 Recurrent myxoinflammatory fibroblastic sarcoma.

Case 36


84-year-old man with right neck cystic nodule Lt511 organizing abscess with numerous multinucleated giant cells

Case 37


83F. Cheek mass. Iac0 Merkel cell carcinoma.

Case 38


27F. History of alveolar rhabdomyosarcoma. Bone marrow biopsy. Iac0 Metastatic alveolar rhabdomyosarcoma.












































Retrieved from "https://learn.mghpathology.org/index.php?title=WSI21-141&oldid=111264"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital